Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Progressive Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.5 (market cap $4.71B), while Progressive Corp trades at $218.9 (market cap $124.28B). The key difference: Progressive Corp is far larger — about 26.4× Definium Therapeutics Inc. Common Shares's market cap, and Progressive Corp pays a 0.19% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Progressive Corp for 81 Days on average.
| DFTX | PGR | |
|---|---|---|
Market Cap | $4.71B | $124.28B |
Volume | 1,966,636 | 2,551,191 |
Sector | Health | Financials |
52-Week High | $48.45 | $242.16 |
52-Week Low | $10.68 | $190.40 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $3.67B | $132.48B |
Dividend Yield | — | 0.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive Corporation (PGR) trades at $214.12, up 0.98% with a bullish technical outlook. The stock shows strong fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Valuation metrics appear reasonable with P/E of 10.74 and ROE of 34.94%. Recent earnings beat expectations in Q2 2026, and analyst consensus targets $222.23.
PGR presents a compelling investment case with consistent revenue growth and strong profitability. However, investors face risks from intensifying auto insurance competition and potential margin pressure. The stock's current price near resistance levels suggests limited near-term upside despite positive analyst sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
